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ABSTRACT 
 
Introduction: Viridans streptococci group such as Streptococcus sanguinis (S. sanguinis), an 
anaerobic Gram-positive bacteria is a well-known for its involvement in dry socket (alveolar 
osteitis)-associated infection. Systemic amoxicillin, clindamycin and metronidazole have all 
been shown to be effective to inhibit this bacterium. However, there has been a lack of studies 
identifying which are the most effective amongst these antibiotics toward Streptococcus 
sanguinis. Objectives: The purpose of this study is to evaluate the effectiveness of 
metronidazole, clindamycin, and amoxicillin in inhibiting the growth of Streptococcus 
sanguinis in vitro. Methods: This effectiveness was done by using agar well diffusion 
methods. S. sanguinis ATCC 10556 were cultured in Brain Heart Infusion (BHI) broth at 37°C 
under anaerobic condition. After 48h, bacterial cells were harvested and counted using 
microplate reader (490 nm) to achieve optical density of 0.25-0.30 (107 CFU/mL). 
Subsequently, 100 μL of bacterial suspension was cultured on BHI agar and each antibiotic 
suspension was added into each agar well, incubated for 72h at 37°C. The inhibition zone 
diameters were measured with electronic caliper. All experiments were done in triplicate, and 
repeated two times in separated occasions. The obtained data were statistically analyzed using 
one-way ANOVA test. A  p<0.05 was considered as significance. Result: The results showed 
that there was a significant difference in the effectiveness, clindamycin and amoxicillin in 
inhibiting the growth of Streptococcus sanguinis (p<0.05), compared to metronidazole. The 
inhibition zone diameter with mean±SD (mm) are 13.50±2.0, 34.67±2.3 and 32.67±1.7 for 
metronidazole, clindamycin and amoxicillin, respectively. Conclusion: Clindamycin and 
amoxicillin are more effective in inhibiting the growth of Streptococcus sanguinis compared to 
metronidazole in this study. However, future studies are needed to confirm this result in vivo. 
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INTRODUCTION 
 
The most common bacteria associated with dry 
socket-related infection , one of common complications 
of post extraction case are the viridans group of 
streptococci such as Streptococcus viridans (S. viridans). 
S. viridans can be found in the oral cavity, oropharynx, 
gastrointestinal tract, and genitourinary.1,2 Study has 
reported that the most common organism isolated from a 
root canal is Streptococcus α−haemolyticus, a group that 
includes S. viridans.3 In dentistry, S. viridans has been 
known as the cause of odontogenic infection.4 S. 
sanguinis is part of the S. viridans group, a facultative 
anaerobic Gram-positive bacteria, which is a normal 
member of the microflora in the human oral cavity.5 
Topical and systemic antibiotics can decrease the dry 
socket incidence rate by preventing the related bacterium 
growth. The use of antibiotics such as clindamycin and 
amoxicillin are effective to treat the dry socket-associated 
infection.6 
 
Metronidazole is used to treat many broad-spectrum 
infections by stopping bacterial or parasitic growth.7 
Metronidazole is highly effective against anaerobic 
Gram-positive and Gram-negative bacteria. Oral 
administration of this antibiotic will be well absorbed, 
spread systemically, and can reach up to 4-6 µg/mL of 
serum levels if 250 mg of metronidazole was taken.8 
Metronidazole is metabolized in the liver through 
oxidation, hydroxylation, and conjugation process. In 
particular, this antibiotic is known for its effectiveness 
against anaerobic Gram-positive Streptococcus viridans, 
including S. sanguinis.9 
 
Clindamycin (a derivative form of lincomycin)  is 
another effective antibiotic against Gram-positive and 
Gram-negative bacteria.10 Compared to lincomycin, 
clindamycin has been prescribed more frequently  
because it has better absorption through the 
gastrointestinal lining, leads to a higher concentration of 
the medicine in the serum. Although lincomycin has the 
same spectrum and mechanism as clindamycin, 
lincomycin has less effectiveness both in vitro and in vivo 
as compared to clindamycin.11 
 
Amoxicillin is a broad-spectrum penicillin group, 
and is highly effective against Gram-positive bacteria 
that do not produce β-lactamase.12 If taken orally, 
amoxicillin is more stable in acidic conditions without 
being affected by foods, has lower incidence of diarrhea, 
and can be absorbed better than ampicillin in the 
gastrointestinal tract. Orally administered amoxicillin is 
effective against facultative Streptococcus bacteria.13 
 
Systemic metronidazole, clindamycin and 
amoxicillin are all effective against oral pathogen. 
However,    there is a lack of studies identifying which of  
these antibiotics is the most effective toward dry socket 
infection. The objective of this study is to evaluate the 
effectiveness of metronidazole, clindamycin, and 
amoxicillin in inhibiting the growth of S. sanguinis in 
vitro. 
 
MATERIALS AND METHODS 
 
Preparation of the Metronidazole, Clindamycin 
and Amoxicillin Solutions 
 
A tablet containing 500 mg of metronidazole and a 
tablet containing 500 mg of amoxicillin were crushed 
separately into powder and diluted in 2 mL of aquadest. 
A capsule containing 300 mg of clindamycin was diluted 
in 1.2 mL of aquadest. The concentration of each solution 
was set to be 25% in a 1.5 mL microcentrifuge tube. 
 
Streptococcus sanguinis  Culture 
 
S. sanguinis ATCC 10556 was obtained from 
MiCORE Laboratory, Faculty of Dentistry, at Trisakti 
University. The bacterium was cultured in brain heart 
infusion (BHI) medium broth (Thermo Fisher Scientific, 
USA) and incubated at 37°C for 48h under anaerobic 
conditions using gaspack jar system.14,15  
  
Minimum Inhibititory Concentration (MIC) Test 
 
The metronidazole, clindamycin, and amoxicillin 
inhibition zone tests were performed using the agar well 
diffusion method. Each plate containing the agar medium 
was punctured using a perforator to create a well with a 5 
mm diameter and was labelled with the name of each 
antibiotic. The wells were filled with 50 µl of the 
metronidazole, clindamycin and amoxicillin solutions, 
respectively. A plate of 3 wells containing aquadest was 
used as a negative control. All petri dishes were 
incubated for 24h at 37°C in anaerobic atmosphere as 
mentioned above. The resulted inhibition zone 
diameters were measured with an electronic caliper. All 
treatments were done in triplicate, and repeated two 
times. 
 
RESULTs in separated occasion 
 
The results showed that there was a significant 
difference in the effectiveness of clindamycin and 
amoxicillin in inhibiting the growth of Streptococcus 
sanguinis (p<0.05). The result of the MIC test showed 
that inhibition zones were formed after 24h of incubation. 
The test found that metronidazole had a mean value of 
13.50±2.0 mm for its inhibition zone against S. sanguinis, 
clindamycin measured 34.67±2.3 mm, and amoxicillin 
32.67±1.7 mm (Fig.1 & Fig.2). The normality test 
showed the data to be normally  distributed  with  a  value 
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of p>0.05. The one-way ANOVA test showed that there 
was a significant difference between metronidazole, 
clindamycin, and amoxicillin in inhibiting the growth of 
S. sanguinis bacteria (p=0.000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Inhibition zones of metronidazole (A), clindamycin 
(B), and amoxicillin (C) against Streptococcus sanguinis tests 
were performed using the agar well diffusion method. All 
treatments were done in triplicate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The graphic above shows the mean value of the 
inhibition zones against Streptococcus sanguinis after addition 
of metronidazole, clindamycin, and amoxicillin solutions in 
their respective wells. The metronidazole solution demonstrated 
the lowest inhibition zone (13.5 mm), while clindamycin had 
the highest inhibition zone with a mean of 34.67 mm. The 
amoxicillin solution’s inhibition zone was  32.67 mm. 
 
DISCUSSION 
 
The results of this study demonstrated that there was 
a significant difference in the inhibitory activity of 
clindamycin and amoxicillin against S. sanguinis, 
compared to the control. In this study, metronidazole that 
used as a control, showed the lowest (p<0.05) inhibitory 
activity compared to the other tested antibiotics 
(clindamycin and amoxicillin).On the other hand, there 
was no significant difference between clindamycin and 
amoxicillin inhibition activity against the bacterium 
tested. 
 
Metronidazole is an antibiotic that belongs to 
nitroimidazole group.7 After being diffused into the 
intracellular protein transport of an organism, 
metronidazole interacts with its DNA by damaging the 
DNA helix structure. This will lead to DNA breakage and 
the inhibition of protein synthesis, causing the death of 
this organism.16 This antibiotic has complete success in 
inhibiting anaerobic bacteria such as Bacteriodes sp. 
(including Bacteroides fragilis), Fusobacterium and 
Clostridium sp. (including Clostridium difficile).17 
 
The antimicrobial activity of clindamycin includes 
aerobic Gram-positive bacteria, anaerobic Gram-positive 
and Gram-negative bacteria, and certain species of 
protozoa. Clindamycin can be considered bacteriostatic 
or bactericidal, depending on the bacterial species. It has 
a high activity against Gram-positive cocci, including S. 
pneumoniae, S. viridans, S. pyogenes, and S. aureus.11 
Lincosamide antibiotics bind to the 23S rRNA of the 50S 
ribosomal subunit, thus interfering and inhibiting protein 
synthesis and leading to subsequent cell death.18 
Clindamycin generates a higher serum level, thus it is 
considered a more potent drug than lincomycin.19  
 
Amoxicillin is a semi synthetic antibiotic that 
belongs to the β-lactam penicillin group. As the most 
common antibiotic prescribed by dentists, it treats broad-
spectrum antimicrobial infections with a bacteriolytic 
mechanism.20 It is effective against Gram-positive and 
Gram-negative bacteria. Generally, this antibiotic is 
effective against bacteria such as Streptococcus, Bacillus 
subtilis, Enterococcus, Haemophilus, Helicobacter, and 
Moraxella. This antibiotic is highly effective against β-
lactamase non-producing Gram-positive bacteria and can 
be easily diffused into the Gram-negative bacterial cell 
wall compared to benzilpenicillin.21 The mechanism of 
amoxicillin is to inhibit the synthesis of the wall cell of 
the bacteria by binding one-to-another along penicillin-
protein bonds (PBPs-Protein Binding Penicillin). These 
bonds inhibit the ending of trans-peptidase peptidoglycan 
synthesis in a bacterial cell, preventing biosynthesis and 
rupturing the cell.22 
 
Both Gram-positive and Gram-negative bacterial cell 
walls are susceptible to the mechanism of this antibiotic. 
Gram-negative bacteria are more prone to develop 
resistance against this antibiotic because they contain 
thinner layer of cell wall compared to Gram-positive 
bacteria,23  but Gram-positive bacteria (including viridans 
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group streptococci) can also develop such a defense 
mechanism toward penicillin antibiotics.24 
 
This study shows that the metronidazole solution has 
the smallest inhibition zone compared to clindamycin and 
amoxicillin. A clinical study of metronidazole as a pre- 
and post-operational treatment, which reported that there 
was insignificant decrease in the incidence of dry 
socket.25 These results are in agreement with Mombelli et 
al. (2015) which states that the Streptococcus viridans 
group showed less susceptibility to metronidazole, as the 
viridans group of streptococci were more prone to 
develop resistance genes to antibiotics. Therefore, the 
synergistic effects of metronidazole and other antibiotic 
combinations, such as amoxicillin, have been highly 
suggested.26  
 
The results of this study also showed that the 
clindamycin solution has the largest inhibition zone, 
which had a mean value 34.67 mm. The clindamycin 
solution therefore has strongest inhibition effect against 
Streptococcus sanguinis. A comparative study between 
clindamycin and ampicillin (belonging to the penicillin 
group) was conducted to treat odontogenic infections.27 
According to the results of this study, clindamycin was 
considered to be more effective than ampicillin in 
eradicating odontogenic bacteria.28 No resistance against 
this antibiotic was observed in any of the isolates, 
whereas the prevalence of ampicillin resistance among 
those isolates was quite high27,28 conducted another study 
to look at the susceptibility of the viridans group of 
streptococci in blood samples to eight different 
antibiotics (including amoxicillin and clindamycin). 
 
It has been reported that clindamycin was more 
effective and efficient against S. sanguinis in vitro, 
because clindamycin had relatively lower MIC values 
than amoxicillin. The MIC50 value of clindamycin was 
0.047 mg/L, while the MIC50 value for amoxicillin was 
0.094 mg/L. Clindamycin has a MIC90 value of 0.19 
mg/L, while amoxicillin has a MIC90 value of 4.0 mg/L 
due to the resistance of the viridans group of streptococci. 
This result was compatible with Triegel and Schlagel’s 
statement, that the etiology of dry socket is related to 
anaerobic bacterial infection and clindamycin is effective 
in preventing dry socket.29 
  
CONCLUSION 
 
Based on this research, it can be concluded that there 
was a difference in the inhibition effect among 
metronidazole, clindamycin, and amoxicillin. Clinda-
mycin and amoxicillin are more effective in inhibiting the 
growth of Streptococcus sanguinis compared to metro-
nidazole since Streptococcus sanguinis is a bacterium 
most commonly reported for its involvement in dry 
socket’s case. However, future studies are needed to 
confirm this result in vivo. 
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